netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Formulary Chapter 9: Nutrition and blood - Full Chapter  Expand sub section  Phosphate supplements
Phosphate supplements (Phosphate-Sandoz®)
View adult BNF View childrens BNF
First Choice
Amber 2
Effervescent tablet
  • Contains 16.1mmol phosphate, 20.4mmol sodium and 3.1mmol potassium per tablet
  • see local hypophosphataemia or refeeding syndrome (a common cause of hypophosphataemia) guidance below
  • link to SPC 
  • Phosphate Polyfusor®
    View adult BNF View childrens BNF
    Restricted Drug Restricted

    500ml polyfusor

    • SFH only
    • A 500ml polyfusor contains phosphate 50mmol, potassium 8mmol and sodium 81mmol. See local guidelines regarding dosage required.
    • If Phosphate polyfusor unavailable see guide for using sodium glycerophosphate.
    Potassium dihydrogen phosphate
    (Potassium acid phosphate)
    Restricted Drug Restricted
    Injection (contains 10mmol/10ml)
  • NUH and SFH: This concentrated product is restricted to authorised areas, stored segregated from other injectables and treated as a Controlled Drug. See NUH IV guide or SFH Concentrated Potassium policy for details
  • NUH only: Infusion (9mmol in 250 ml sodium chloride 0.9% bag) - ready made bag available from Pharmacy
  • Unlicensed medicine - named patient use only
  • Caution: The rate and concentration recommended for potassium infusions must never be exceeded (see local potassium replacement guidance)
  • Link  SFH outpatients should be sent to SFH pharmacy for supplies of unlicensed medicines. Don’t prescribe on FP10HP.
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Track Changes
    Display tracking information
    click to search
    Link to adult BNF
    click to search
    Link to children's BNF
    click to search
    Link to SPCs
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHS England

    Traffic Light Status Information

    Status Description


    Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
    Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
    Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.


    Medicines which should normally be prescribed by specialists only. eg hospital only.
    For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

    Amber 1

    Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
    Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.

    Amber 2

    Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
    A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
    *Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice

    Amber 3

    Primary care/ non specialist may initiate as per APC guideline.
    The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.


    Medicines suitable for routine use within primary care.
    Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.